The CEO, Keith Berman, was sentenced on Friday to seven years in prison for the fraud that led to $28 million in investor losses, according to the Department of Justice.

The CEO of biotech company Decision Diagnostics Corp., Keith Berman, was sentenced to seven years in prison for a securities fraud scheme that resulted in about $28 million in investor losses and ...

The chief executive of a U.S. biotechnology company that falsely promised investors it could produce a quick and accurate COVID-19 test was sentenced to seven years' in jail on Friday, the Justice ...

Keith Berman, the CEO of Decision Diagnostics Corporation (DECN), was indicted for securities fraud after investors purchased stock in his company hoping to profit from a revolutionary COVID-19 ...

The U.S. Department of Justice announced that Keith Berman, formerly the CEO of Los Angeles-based Decision Diagnostics Corp., has received a prison sentence of seven years for misrepresenting the ...

Keith Berman, 70, of Westlake Village ... of a U.S. biotechnology company that falsely promised investors it could produce a quick and accurate COVID-19 test was sentenced to seven years' in jail ...

The chief executive of a U.S. biotechnology company that falsely promised investors it could produce a quick and accurate COVID-19 test was sentenced to seven years' in jail on Friday, the Justice ...

He claimed his company had developed a test to detect Covid-19 in a finger-prick sample of blood. Read more at straitstimes.com. Read more at straitstimes.com.